Navigation Links
S&P Capital IQ Picks Celgene Focus Stock of the Week
Date:10/24/2011

NEW YORK, Oct. 24, 2011 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG: $68) has been picked by S&P Capital IQ as its Focus Stock of the Week.  CELG carries S&P Capital IQ's highest investment recommendation of 5-STARS, or Strong Buy.

"We consider Celgene to be among the best positioned biotechs for long-term growth, with solid core product growth," said Steven Silver, Biotech Equity Analyst at S&P Capital IQ.  "We believe the strength of the company's advancing pipeline of products is not appropriately reflected in the current share price."

Silver projects Celgene to grow earnings at a compound annual rate of 21% from 2010 through 2013.  He adds that this figure represents the brightest growth prospects S&P Capital IQ sees in the large-cap biotechnology industry, driven by expanding global sales of key cancer drug Revlimid.

To view a video of Mr. Silver discussing CELG, paste the following link into your browser.

http://link.delvenetworks.com/media/?mediaId=ed769c3c6ebb4af2869623b48de17cdc&width=480&height=411&playerForm=DelvePlayer&autoplay=true

About S&P Capital IQ

S&P Capital IQ, a brand of the McGraw-Hill Companies (NYSE: MHP), is a leading provider of multi-asset class data, research and analytics to institutional investors, investment advisors and wealth managers around the world.  We provide a broad suite of capabilities designed to help track performance, generate alpha, identify new trading and investment ideas, and perform risk analysis and mitigation strategies.  Through leading desktop solutions such as Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions suc
'/>"/>

SOURCE S&P Capital IQ
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
2. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
3. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
4. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
5. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
6. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
7. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
8. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
9. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
10. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
11. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Research and Markets  has announced the ... Polymer, Food & Beverage, Personal Care & Pharmaceutical) ... report to their offering. Lactic acid ... carbon atom. The main applications of lactic acid ... personal care product, and pharmaceutical industries. Lactic ...
(Date:8/27/2014)... “We are honored to be named to this ... of Radiant Sage. “We are offering truly ground-breaking clinical ... market to a different level. We are enabling ... and effectively manage the massive amounts of medical imaging ... read by trained physicians. Being recognized by technology industry ...
(Date:8/27/2014)... Flagship Biosciences LLC, a leading provider ... pharmaceutical and medical device industries, has announced a laboratory ... company has consolidated its histology and tissue analysis operations ... CO, just north of Denver. The new addresses ... Ave., Suite 100, Westminster, CO 80021 , Tissue Image ...
(Date:8/27/2014)... -- ARCH Venture Partners, one of the largest U.S. ... seed and early-stage advanced technology companies, today announced ... than $400 million in subscriptions. ARCH Venture Fund ... more than $150 million. "The enthusiasm ... of our approach to finding and funding new ...
Breaking Biology Technology:Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Flagship Biosciences Announces Relocation and Expansion 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... "We Want to Double our Sales Within Three Years", ... in,sales of EUR 3.4 million to EUR 17 million, ... the path of significant growth in 2007. "We want ... years," states CEO Nikolaus Uleer.,With the construction of the ...
... 10 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today ... 2007 after the NASDAQ Global Market closes on Wednesday,October ... and,Chief Executive Officer, and Robert E. Hoffman, Arena,s Vice ... call at 5:00,p.m. Eastern Time (2:00 p.m. Pacific Time) ...
... (ED) hold a,critical key in improving acute coronary ... all the tools that you need to improve ... to Better Myocardial,Infarction Outcomes: Emergency Departments Hold the ... experts, Deborah Diercks, MD; James Hoekstra, MD; and,Charles ...
Cached Biology Technology:Dr. Suwelack Skin & Health Care: New Product in the FDA Certification Process 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 2Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007 3UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 2UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key 3
(Date:8/27/2014)... that exists as five strains, none of which have ... the Sudan ebolavirus (SUDV). Although not the strain currently ... as recently as 2012. In a new study appearing ... now report a possible therapy that could someday help ... Sidhu, Jonathan Lai and colleagues explain that about 50-90 ...
(Date:8/27/2014)... or abandoned each year in U.S. waters and become ... catch fish, crabs, and other species such as turtles. ... the watermen who depend on the resources--losses that are ... , The report, published in the Marine Pollution ... examine the derelict fish trap problem, and so-called "ghost ...
(Date:8/27/2014)... has shown that piglets can be weaned later with ... outcome of the study at the University,s Roseworthy campus, ... is an important finding for pig producers. It allows ... production. , "Sows don,t usually start their oestrous cycles ... piglets have been weaned," says Ms Alice Weaver, PhD ...
Breaking Biology News(10 mins):Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2Piglet weaning age no bar to litter frequency 2
... The New York Stem Cell Foundation (NYSCF) Research Institute in ... Mount Sinai (ISMMS) successfully generated a stem cell model of ... identified fourteen genes that may be implicated in the disease ... inflammation may play in the brain of Alzheimer,s patients. ...
... 2014)- The leatherback turtle in the Pacific Ocean is one ... has declined by more than 90 percent since 1980. One ... set thousands of hooks in the ocean to catch fish, ... technology, researchers are now able to predict where fisheries and ...
... with a heart defect such as a hole in the heart, ... quickly and safely secure devices inside the heart. Sutures take too ... tissue, and currently available clinical adhesives are either too toxic or ... or under dynamic conditions, such as in a beating heart. ...
Cached Biology News:Stem cell research identifies new gene targets in patients with Alzheimer's disease 2Stem cell research identifies new gene targets in patients with Alzheimer's disease 3GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 2GPS traffic maps for leatherback turtles show hotspots to prevent accidental fishing deaths 3Bio-inspired glue keeps hearts securely sealed 2Bio-inspired glue keeps hearts securely sealed 3
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA....
EnzChek cellulase substrate *blue fluorescent, 339/452...
... Kb RNA Ladder is suitable for sizing single-stranded RNA ... or formaldehyde agarose gels. The ladder consists of nine ... 4 6 8 and 10 kb) to simplify size ... the other bands allowing easy orientation and identification of ...
...
Biology Products: